IPATF - ImmunoPrecise antibodies to kick-off trading on NASDAQ
Therapeutic antibody discovery and development company ImmunoPrecise Antibodies' (IPATF) shares have been approved for listing on the NASDAQ Global Market under the trading ticker symbol "IPA."Trading is expected to commence on December 30.The company's shares will continue to trade on TSX Venture Exchange under the symbol "IPA"."We believe the NASDAQ Global Market will enhance long-term shareholder value by improving the Company's visibility, increasing liquidity, and appealing to institutional investors," CEO Jennifer Bath said.
For further details see:
ImmunoPrecise antibodies to kick-off trading on NASDAQ